Search

Author/Creator Kessler, C. M.

2. Assessment of individual dose utilization vs. physician prescribing recommendations for recombinant activated factor VII (rFVIIa) in paediatric and adult patients with congenital haemophilia and alloantibody inhibitors (CHwI): the Dosing Observational Study in Hemophilia (DOSE). (1st April 2013)

Authors:
Gruppo, R. A.; Kessler, C. M.; Neufeld, E. J.; Cooper, D. L.
Journal:
Haemophilia
Issue:
Volume 19:Number 4(2013:Jul.)
Page Start:
524
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach. Issue 8 (14th August 2013)

Authors:
Kittelson, J. M.; Spyropoulos, A. C.; Halperin, J. L.; Kessler, C. M.; Schulman, S.; Steg, G.; Turpie, A. G. G.; Cutler, N. R.; Hiatt, W. R.; Goldenberg, N. A.
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 11:Issue 8(2013)
Page Start:
1443
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Efficacy and safety of a VWF/FVIII concentrate (wilate®) in inherited von Willebrand disease patients undergoing surgical procedures. Issue 2 (27th December 2016)

Authors:
Srivastava, A.; Serban, M.; Werner, S.; Schwartz, B. A.; Kessler, C. M.
Other Names:
Alkindi Salam investigator.; Apte Shashikant Janardan investigator.; Castaman Giancarlo investigator.; Gill Joan Cox investigator.; Hellmann Andrzej investigator.; Kavakli Kaan investigator.; Kouides Peter A. investigator.; Kuriakose Philip investigator.; Lissitchkov Toshko investigator.; Ma Alic...
Journal:
Haemophilia
Issue:
Volume 23:Issue 2(2017)
Page Start:
264
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗